AU:NTI Stock Latest News
Company AnnouncementsNeurotech International Reports Director Shareholding Change1d agoNTI
Company AnnouncementsNeurotech Issues Shares and Provides Secondary Trading Notice2d agoNTI
Company AnnouncementsNeurotech Notifies Issue of Unquoted Options2d agoNTI
Company AnnouncementsNeurotech Notifies ASX of Two Unlisted Option Classes2d agoNTI
Company AnnouncementsNeurotech International Reports Change in Director’s Share Interests1w agoNTI
Company AnnouncementsNeurotech International Reports Director Departure and Shareholding1w agoNTICompany AnnouncementsNeurotech advances autism drug NTI164 with Phase 3 trial, FDA IND and new funding3w agoNTI
Company AnnouncementsNeurotech Flags High Risks as It Pursues Neurodevelopmental Disorder Therapies1M agoNTI
Company AnnouncementsNeurotech Director Andrew Chapman Boosts Equity Stake1M agoNTI
Company AnnouncementsNeurotech International Releases 2026 Annual Report1M agoNTI
Company AnnouncementsNeurotech International Sets November AGM, Moves to Digital Meeting Materials1M agoNTI
Company AnnouncementsNeurotech’s NTI164 Autism Trial Enters Phase III: What Investors Should Watch1M agoNTICompany AnnouncementsNTI164 Rett Trial Moves Toward Phase II/III: What Investors Should Watch2M agoNTI
Company AnnouncementsNeurotech International Adds Major Shareholder Andrew Chapman to Board2M agoNTI
Company AnnouncementsNeurotech International Options Lapse Simplifies Capital Structure2M agoNTI
Company AnnouncementsNeurotech reshapes board as it advances paediatric cannabinoid trials2M agoNTI
Company AnnouncementsNeurotech Discloses Final Director Interest as Anthony Filippis Steps Down2M agoNTI
Company AnnouncementsNeurotech Narrows Loss as R&D Grants Drive Revenue Surge2M agoNTICompany AnnouncementsNeurotech Elevates Mark Davies to Executive Chairman as Phase III Cannabinoid Program Advances3M agoNTI


